Here are 5 important questions to ask if you’ve been told you have cervical dysplasia: ...

Human papillomavirus (HPV) vaccines are in wide use around the world ... 3 years of follow-up. The investigators assessed the efficacy of the vaccine against cervical intraepithelial neoplasia ...

Another term for cervical dysplasia is cervical intraepithelial neoplasia, or CIN. The exact cause of cervical dysplasia is not known, however it has been linked to the human papillomavirus (HPV).

[6] Cervical histological diagnoses were categorized as CIN 2, CIN 2 or worse (CIN 2+, i.e., CIN 2, CIN 3, cervical adenocarcinoma ... cytological result of ASC-US or LSIL who underwent excisional ...

the vaccine was 100% effective in preventing cervical intraepithelial neoplasia (CIN)1-3 and adenocarcinoma in situ (AIS) associated with HPV 16 and 18. In the FUTURE I intention-to-treat group ...

In those with grade 3 cervical intraepithelial neoplasia (CIN3), cells are already on the path toward malignancy. If left untreated, approximately one-third of these cases progress to cervical ...

Refika Yigit, MD, principal investigator and oncological gynecologist at University Medical Centre Groningen, Netherlands In those with grade 3 cervical intraepithelial neoplasia (CIN3), cells are ...

“Our findings demonstrate that the therapeutic vaccine Vvax001 is safe, well-tolerated, and effective in eradicating HPV16-associated CIN3 lesions and clearing the underlying persistent HPV16 ...

Patients with one or two negative HPV tests had risks of grade 2 or higher cervical intraepithelial neoplasia (CIN2+) of 3.2 ...